These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status. Singh VK; Hauer-Jensen M Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057 [TBL] [Abstract][Full Text] [Related]
3. A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol. Cheema AK; Mehta KY; Fatanmi OO; Wise SY; Hinzman CP; Wolff J; Singh VK Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283379 [TBL] [Abstract][Full Text] [Related]
4. A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation. Pannkuk EL; Laiakis EC; Fornace AJ; Fatanmi OO; Singh VK Health Phys; 2018 Jul; 115(1):3-11. PubMed ID: 29787425 [TBL] [Abstract][Full Text] [Related]
5. Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate. Garg S; Garg TK; Wise SY; Fatanmi OO; Miousse IR; Savenka AV; Basnakian AG; Singh VK; Hauer-Jensen M Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563033 [TBL] [Abstract][Full Text] [Related]
6. THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY. Singh VK; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Seed TM Radiat Prot Dosimetry; 2016 Dec; 172(1-3):302-310. PubMed ID: 27542813 [TBL] [Abstract][Full Text] [Related]
7. Pathology of acute sub-lethal or near-lethal irradiation of nonhuman primates prophylaxed with the nutraceutical, gamma tocotrienol. Singh VK; Wise SY; Fatanmi OO; Petrus SA; Carpenter AD; Lugo-Roman LA; Lee SH; Hauer-Jensen M; Seed TM Sci Rep; 2024 Jun; 14(1):13315. PubMed ID: 38858439 [TBL] [Abstract][Full Text] [Related]
9. Progenitor Cell Mobilization by Gamma-tocotrienol: A Promising Radiation Countermeasure. Singh VK; Fatanmi OO; Verma A; Newman VL; Wise SY; Romaine PL; Berg AN Health Phys; 2016 Aug; 111(2):85-92. PubMed ID: 27356050 [TBL] [Abstract][Full Text] [Related]
10. Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol. Singh VK; Wise SY; Fatanmi OO; Petrus SA; Carpenter AD; Lee SH; Hauer-Jensen M; Seed TM Sci Rep; 2024 Mar; 14(1):5757. PubMed ID: 38459144 [TBL] [Abstract][Full Text] [Related]
15. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Ghosh SP; Kulkarni S; Hieber K; Toles R; Romanyukha L; Kao TC; Hauer-Jensen M; Kumar KS Int J Radiat Biol; 2009 Jul; 85(7):598-606. PubMed ID: 19557601 [TBL] [Abstract][Full Text] [Related]
16. Metabolomic Profiles in Tissues of Nonhuman Primates Exposed to Either Total- or Partial-Body Radiation. Carpenter AD; Li Y; Fatanmi OO; Wise SY; Petrus SA; Janocha BL; Cheema AK; Singh VK Radiat Res; 2024 May; 201(5):371-383. PubMed ID: 38253059 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing. Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533 [TBL] [Abstract][Full Text] [Related]
18. Gamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model. Garg TK; Garg S; Miousse IR; Wise SY; Carpenter AD; Fatanmi OO; van Rhee F; Singh VK; Hauer-Jensen M Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555814 [TBL] [Abstract][Full Text] [Related]
19. Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection. Ledet GA; Biswas S; Kumar VP; Graves RA; Mitchner DM; Parker TM; Bostanian LA; Ghosh SP; Mandal TK Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029115 [TBL] [Abstract][Full Text] [Related]